Kp Tissue Stock Today
| KPT Stock | CAD 10.30 0.03 0.29% |
PerformanceSolid
| Odds Of DistressTiny
|
KP Tissue is selling at 10.30 as of the 9th of February 2026; that is 0.29 percent increase since the beginning of the trading day. The stock's open price was 10.27. KP Tissue has under 5 % chance of experiencing financial distress over the next 2 years and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 11th of November 2025 and ending today, the 9th of February 2026. Click here to learn more.
Business Domain Household & Personal Products | Category Consumer Defensive | Classification Consumer Staples |
KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in North America. KP Tissue Inc. was founded in 2012 and is headquartered in Mississauga, Canada. KP TISSUE operates under Household Personal Products classification in Canada and is traded on Toronto Stock Exchange.. The company has 10.01 M outstanding shares of which 345.08 K shares are now shorted by private and institutional investors with about 31.33 days to cover all short positions. More on KP Tissue
Moving together with KPT Stock
Moving against KPT Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
KPT Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. KP Tissue's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding KP Tissue or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
KP Tissue (KPT) is traded on Toronto Exchange in Canada and employs 12 people. KP Tissue is listed under Personal Care Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 101.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate KP Tissue's market, we take the total number of its shares issued and multiply it by KP Tissue's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. KP Tissue operates under Personal Care Products sector and is part of Consumer Staples industry. The entity has 10.01 M outstanding shares of which 345.08 K shares are now shorted by private and institutional investors with about 31.33 days to cover all short positions.
KP Tissue may have liquidity issues
Check KP Tissue Probability Of Bankruptcy
Ownership AllocationThe market capitalization of KP Tissue is C$101.78 Million. Around 98.88 % of KP Tissue outstanding shares are held by general public with 0.47 percent owned by insiders and only 0.65 (percent) by institutions. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check KPT Ownership Details
KP Tissue Historical Income Statement
KPT Stock Against Markets
KPT Stock Analysis Notes
The company has price-to-book ratio of 1.48. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. KP Tissue has Price/Earnings To Growth (PEG) ratio of 1.44. The entity last dividend was issued on the 31st of December 2025. KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in North America. KP Tissue Inc. was founded in 2012 and is headquartered in Mississauga, Canada. KP TISSUE operates under Household Personal Products classification in Canada and is traded on Toronto Stock Exchange. To find out more about KP Tissue contact the company at 905-812-6900 or learn more at https://www.kptissueinc.com.KP Tissue Investment Alerts
| Latest headline from news.google.com: KP Tissue Tracks SPTSX Composite in Consumer Defensives - Kalkine Media |
KPT Largest EPS Surprises
Earnings surprises can significantly impact KP Tissue's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2019-08-08 | 2019-06-30 | 0.03 | 0.04 | 0.01 | 33 | ||
2025-03-05 | 2024-12-31 | 0.1847 | 0.166 | -0.0187 | 10 | ||
2022-11-09 | 2022-09-30 | -0.14 | -0.12 | 0.02 | 14 |
KPT Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 101.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate KP Tissue's market, we take the total number of its shares issued and multiply it by KP Tissue's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.KPT Profitablity
KP Tissue's profitability indicators refer to fundamental financial ratios that showcase KP Tissue's ability to generate income relative to its revenue or operating costs. If, let's say, KP Tissue is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, KP Tissue's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of KP Tissue's profitability requires more research than a typical breakdown of KP Tissue's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.03 | 0.03 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.03 | 0.03 |
Management Efficiency
As of the 9th of February 2026, Return On Tangible Assets is likely to grow to 0.03. Also, Return On Assets is likely to grow to 0.03. At this time, KP Tissue's Asset Turnover is very stable compared to the past year. KP Tissue's management efficiency ratios could be used to measure how well KP Tissue manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.01 | 12.23 | |
| Tangible Book Value Per Share | 8.01 | 12.23 | |
| Enterprise Value Over EBITDA | 0.28 | 0.29 | |
| Price Book Value Ratio | 1.06 | 0.93 | |
| Enterprise Value Multiple | 0.28 | 0.29 | |
| Price Fair Value | 1.06 | 0.93 | |
| Enterprise Value | 127.5 M | 113.3 M |
Leadership effectiveness at KP Tissue is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 9th of February, KP Tissue owns the Mean Deviation of 0.5842, standard deviation of 0.8309, and Market Risk Adjusted Performance of 1.98. KP Tissue technical analysis lets you operate past data patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.KP Tissue Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. KP Tissue Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe KP Tissue price patterns.
KP Tissue Outstanding Bonds
KP Tissue issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. KP Tissue uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most KPT bonds can be classified according to their maturity, which is the date when KP Tissue has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
KP Tissue Predictive Daily Indicators
KP Tissue intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of KP Tissue stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
KP Tissue Forecast Models
KP Tissue's time-series forecasting models are one of many KP Tissue's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary KP Tissue's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in KP Tissue without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
KP Tissue Corporate Management
Elected by the shareholders, the KP Tissue's board of directors comprises two types of representatives: KP Tissue inside directors who are chosen from within the company, and outside directors, selected externally and held independent of KPT. The board's role is to monitor KP Tissue's management team and ensure that shareholders' interests are well served. KP Tissue's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, KP Tissue's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Franois Paroyan | SVP Secretary | Profile | |
| Marc Fitzgerald | Corporate LP | Profile | |
| Susan Irving | Chief KPLP | Profile | |
| Michael Keays | Chief Officer | Profile | |
| Nancy Marcus | Chief LP | Profile | |
| Robert Martin | Senior Operations | Profile |
Other Information on Investing in KPT Stock
KP Tissue financial ratios help investors to determine whether KPT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KPT with respect to the benefits of owning KP Tissue security.